Phyllis is Vice President, Infectious Diseases and Diagnostics Policy at BIO. In this role, she is responsible for working with member companies in vaccines, molecular diagnostics, and bio-defense on policy, legislative, and regulatory issues. Phyllis joined BIO in July 2009 as the Director of Healthcare Regulatory Affairs.
Prior to joining BIO, she worked in numerous marketing and sales positions for Merck & Co., Inc in their vaccine division. Over her 16 year career, she has launched several exciting new vaccines in the United States and internationally, including the first HPV vaccine GARDASIL. During her years in marketing, she worked closely with clinical and academic thought leaders in infectious diseases, oncology, and public health. In addition, she also led a large vaccine sales organization of over 75 representatives and managers, covering 14 states. Phyllis received her bachelor’s degree in economics and international politics from Goucher College and her M.B.A. from the Wharton School of Business at the University of Pennsylvania.
